GLP-1 Side Effects: What's Common, What's Serious, What to Do

Most people starting a GLP-1 get some gastrointestinal side effects, most of those settle, and a good deal of the discomfort is manageable with fairly ordinary adjustments. A small number of symptoms are different in kind, and those are the ones to be able to recognise.

These drugs slow gastric emptying and act on appetite regulation. Most of the common side effects are the direct, predictable consequence of that. Understanding why something is happening makes it considerably easier to sit with. For the wider picture of how the class works, see our complete guide to GLP-1 medications.

The common effects, and what to do about them

Nausea

The most frequently reported effect by some distance. It tends to peak in the day or two after an injection, and again after each dose step. For most people it lessens over subsequent weeks at the same dose.

What tends to help: eating less at a sitting than you think you need to, and stopping at the first sign of fullness rather than the last. Blander, lower-fat food is easier than rich food. Fried and very fatty meals sit in a slowed stomach for a long time and are a common trigger. Eating slowly matters more than it sounds — the satiety signal now arrives with a delay, and eating at your old pace means you routinely overshoot before you notice. Some people find cold food easier than hot, because it carries less smell. Ginger and peppermint help some people and do nothing for others; they are harmless enough to try.

If nausea is severe or persistent at a given dose, holding at that dose rather than escalating is a normal and sensible clinical decision. Say so at your review.

Constipation

Slower transit through the whole gut, combined with eating less food and often less fibre, produces constipation in a lot of people. It is one of the more persistent effects — it tends not to fade the way nausea does, because the underlying cause does not go away.

Fluid intake is the first thing to address, and it is easy to under-drink when you are not eating much. Fibre helps, though increasing it abruptly can produce bloating; go up gradually. Movement helps. If those are not enough, an over-the-counter osmotic laxative is a reasonable thing to ask a clinician or pharmacist about rather than something to be embarrassed by. Untreated constipation is not merely uncomfortable; it makes nausea worse and, at the extreme, contributes to obstruction.

Diarrhoea

Less common than constipation but not rare, and occasionally the two alternate. Usually mild and short-lived. The thing to watch is fluid loss, particularly if it coincides with vomiting or poor intake, because dehydration on these drugs can affect kidney function.

Reflux and burping

A stomach that empties more slowly is a stomach with contents in it for longer. Reflux, an unpleasant sulphurous burp and a sensation of food sitting high are all commonly described. Smaller meals, not lying down for a few hours after eating, and raising the head of the bed are the usual measures. Persistent reflux is worth mentioning at review rather than living with, especially if you already had it before starting.

Fatigue and injection-site reactions

Tiredness in the first weeks is common and usually reflects a sharp drop in energy intake. Redness or itching at the injection site is generally minor and settles; rotating sites helps.

The relationship between titration and tolerability

Both semaglutide and tirzepatide start at doses that are not expected to produce much effect, stepping up at roughly four-week intervals. That interval is not arbitrary. Gastrointestinal tolerance improves with time at a given dose, so the schedule trades a slower start for a much better chance of staying on treatment.

Three things follow from this. Escalating faster than the labelled schedule mainly produces more side effects and more people stopping. Pausing at a dose you are struggling with, or stepping back down, is a legitimate clinical option rather than a setback. And the maximum dose is not a target — some people do perfectly well at an intermediate dose and have no reason to go higher.

The two drugs also differ somewhat in how people tolerate them, and switching between them is a normal response to persistent trouble. Our comparison of the two goes through what actually differs.

Symptoms that warrant contacting someone

Everything above is the common, self-limiting category. The following is a different category. These are uncommon, but they are the reason this class of drug requires a prescriber rather than a shopping cart.

Severe abdominal pain, particularly radiating to the back

Persistent, severe pain in the upper abdomen that bores through to the back, often with vomiting, is the classic presentation of pancreatitis. It does not feel like ordinary GLP-1 nausea and people who have had it rarely describe it as ambiguous. Stop taking the medication and seek medical assessment. Do not wait to see whether it passes overnight.

Gallbladder symptoms

Substantial and rapid weight loss from any cause increases the risk of gallstones. Pain in the upper right abdomen or under the right shoulder blade, especially after fatty food, with fever, or with yellowing of the skin or eyes, needs prompt evaluation.

Persistent vomiting and dehydration

Vomiting that stops you keeping fluids down for more than a day or so is not something to manage at home. Dehydration on these medications has been associated with acute kidney injury, and the risk is higher if you also take diuretics, ACE inhibitors, ARBs or NSAIDs. Lightheadedness on standing, markedly reduced urine output and dark urine are the signs to act on.

Symptoms of obstruction or severe gastroparesis

Persistent vomiting of undigested food eaten hours or days earlier, inability to pass stool or wind, and a distended painful abdomen require urgent assessment.

Low blood sugar

On their own, GLP-1 medications carry a low risk of hypoglycaemia. Combined with insulin or a sulfonylurea such as glipizide or glyburide, that changes substantially, and those doses usually need reducing when a GLP-1 is started or increased. Shakiness, sweating, confusion, palpitations and unusual hunger are the warning signs. If you take either of those drug classes, this needs to be an explicit conversation with the prescriber, not an assumption.

Allergic reaction

Rash with swelling of the face, lips or tongue, or difficulty breathing, is an emergency. Call 911.

Changes in mood

Report new or worsening depression, or any thoughts of self-harm, to a clinician promptly. This is monitored on weight-management medications generally and is worth raising rather than absorbing.

Two practical points about the rest of your care

Tell any clinician who is planning a procedure requiring sedation or general anaesthesia that you take a GLP-1, well in advance. Delayed gastric emptying affects fasting guidance and anaesthetic planning. The same applies to endoscopy.

And tell your prescriber about everything else you take, including oral contraceptives and any medication where the precise level in your blood matters. Slowed gastric emptying can affect how other drugs are absorbed. This is part of why a proper history matters — see who should not take a GLP-1 for the conditions and interactions that change the answer entirely.

When side effects mean stopping

Side effects that will not settle, at any tolerable dose, are a reason to stop. That is not a failure of persistence. Some people cannot take these drugs, and continuing to feel unwell for months in the hope of adaptation is not a plan.

If treatment does stop, understand what typically follows, because appetite regulation reverts — what happens when you stop a GLP-1 covers that honestly. Whatever you decide, decide it with a clinician who knows your history. Our weight management service includes the follow-up appointments where this kind of adjustment is made, and you can book a consultation if you want to review how treatment is going.